Lancet Oncology

New drug cuts risk of deadly transplant side effect in half

A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments, according to a study from researchers at the University of Michigan Comprehensive ...

Dec 02, 2013
popularity 5 / 5 (1) | comments 0

Cancer in EU cost EUR126 billion in 2009

The results, published in The Lancet Oncology, reveal substantial disparities between different countries in the EU in spending on health care and drugs for cancer, with Luxembourg and Germany spending the most on health ...

Oct 13, 2013
popularity not rated yet | comments 0